TRACON Pharmaceuticals, Inc. (DE:T051)
BERLIN:T051

TRACON Pharmaceuticals Financial Statements

0 Followers

TRACON Pharmaceuticals Financial Overview

TRACON Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; TRACON Pharmaceuticals is scheduled to report earnings on March 2, 2023, and the estimated EPS forecast is €-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -6.38M$ -6.24M$ -9.45M$ -7.66M$ -6.88M
EBITDA$ -6.32M$ -6.21M$ -9.45M$ -7.66M$ -6.88M
Net Income Common Stockholders$ -6.43M$ -6.23M$ -9.47M$ -7.71M$ -6.95M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 17.04M$ 13.58M$ 16.64M$ 24.07M$ 29.90M
Total Assets$ 19.67M$ 15.68M$ 18.86M$ 26.56M$ 32.81M
Total Debt$ 9.10M$ 0.00$ 698.00K$ 1.54M$ 2.08M
Net Debt$ -7.94M$ -13.58M$ -15.94M$ -22.53M$ -27.82M
Total Liabilities$ 22.30M$ 13.13M$ 16.07M$ 14.84M$ 13.95M
Stockholders Equity$ -2.63M$ 2.54M$ 2.79M$ 11.71M$ 18.86M
Cash Flow
Free Cash Flow$ -6.83M$ -8.02M$ -6.75M$ -5.12M$ -8.43M
Operating Cash Flow$ -6.83M$ -8.02M$ -6.74M$ -5.11M$ -8.42M
Investing Cash Flow$ -7.00K$ -2.00K$ -4.00K$ -9.00K$ -9.00K
Financing Cash Flow$ 10.47M$ 4.96M$ -686.00K$ -706.00K$ 12.75M
Currency in USD

TRACON Pharmaceuticals Earnings and Revenue History


TRACON Pharmaceuticals Debt to Assets


TRACON Pharmaceuticals Cash Flow


TRACON Pharmaceuticals Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis